Weight loss and Testosterone Deficiency: T Therapy + GLP-1

[madman]

32:00-44:15

Case: 54-Year-Old Man with Vaculogenic ED

Case Study: Body Composition Transformation

THE EFFECTS OF COMBINED THERAPY ON HORMONAL AND METABOLIC PERFORMANCE

DATA-DRIVEN INSIGHTS: QUANTITATIVE BIOMARKER CHANGES

Thread 'Pioneering study - how GLP-1 therapy combined with KYZATREX® impacts muscle mass and energy levels in male patients undergoing weight loss'

Sep 29, 2024

nuBioAge, nuHx and Marius Pharmaceuticals Team Up for Collaborative GLP-1 Comparison Study in Male Patients

/PRNewswire/ -- nuBioAge, a longevity science and wellness network based in West Palm Beach, has announced a partnership between their new comprehensive...

www.prnewswire.com

WEST PALM BEACH, Fla., Sept. 25, 2024 /PRNewswire/ -- nuBioAge, a longevity science and wellness network based in West Palm Beach, has announced a partnership between their new comprehensive assessment and research center, nuHx, and Marius Pharmaceuticals, the company behind KYZATREX® (testosterone undecanoate) CIII capsules, an FDA-approved oral testosterone treatment for men...

• madman
• glp-1 obesity oral testosterone trt weightloss
• Replies: 2
• Forum: Testosterone and Men's Health Articles

• 

 

[madman]

Thread 'Can GLP‑1 Drugs Like Semaglutide Boost Testosterone? New Review Reveals Surprising Results'

Oct 28, 2025

* Among the human studies, 9 evaluated testosterone levels (total and/or free), 6 reported on gonadotropins (LH, FSH), and 5 assessed clinical hypogonadal symptoms such as libido and erectile function. In total, 7 human studies demonstrated a statistically significant increase in testosterone levels following GLP-1 agonist treatment, with stronger effects observed in men with obesity, T2DM, and baseline low testosterone. Two human studies showed no change or mild reductions in testosterone among eugonadal men without metabolic disease.


* GLP-1 receptor...

• madman
• glp-1 hypogonadism obesity T2dm
• Replies: 2
• Forum: General Peptide Use & Information

 

[madman]

Thread 'The male hormone reset: how GLP-1RAs, lifestyle and testosterone transform obesity-linked problems'

Dec 16, 2025

Figure 1. Comparative overview of therapeutic approaches for male hypogonadism and metabolic dysfunction. The figure summarizes the key advantages and disadvantages of three main management modalities: GLP-1 receptor agonists (GLP-1 RAs), lifestyle modification (diet and exercise), and testosterone therapy (TTh). GLP-1 RAs provide substantial weight loss and cardiovascular benefit but may lead to muscle loss, mood disturbances, and rebound weight gain upon discontinuation. Diet and exercise remain foundational but are limited by adherence challenges. Testosterone therapy exerts...

• madman
• glp-1 hypogonadism lifestyle obesity t therapy
• Replies: 1
• Forum: Testosterone and Men's Health Articles

 

[madman]

Thread 'The Ultimate GLP-1 Guide: Weight Loss, Side Effects & Sarcopenia Risk'

Mar 29, 2026

Are GLP-1 agonists like Ozempic and Mounjaro the future of healthcare or a risk to your health? We break down the latest data on weight loss medication efficacy, common side effects, and the truth about muscle mass loss (sarcopenia).

In This Episode:

Dr. Jordan Feigenbaum and Dr. Austin Baraki are joined by obesity medicine expert Dr. Spencer Nadolsky to provide a comprehensive update on the rapid evolution of anti-obesity medications. We dive deep into the clinical efficacy of GLP-1 receptor agonists, comparing Semaglutide (Wegovy) against...

• madman
• glp-1 lifestyle obesity weight loss
• Replies: 8
• Forum: Weight Loss Options